Current Articles | Syndication

Protein biochip: An innovation for healthcare (19th May 2008) Protein biochip: An innovation for healthcare   Crumlin, UK, 19 May 2008 Randox Laboratories Ltd. release of the world’s first protein biochip and the Evidence immunoassay analyser is set to revolutionise healthcare and diagnosis.    Biochip Array Technology uses a biochip as the reaction platform with multiple individual tests at pre-defined discrete test regions.  When a patient sample is added, each individual test is performed side by side on the biochip surface.  This innovative procedure offers high end technology, producing results rapidly and to the highest standard.    Randox’s Evidence analyser has an extensive range of attributes.  This analyser has an impressive throughput of 108 samples per hour multiplied by the number of tests on the biochip, which can be up to 23 tests.  Not only does the Evidence boast a high throughput, it has a host of advantageous features.  These include clear and easy-to-operate graphic user interface, regular updates of onboard inventory details, QC software, retrospective reporting, results archiving, test selection profiles and LIMS connectivity.    The Evidence analyser is supported by Randox quality controls, 24/7 Internet-driven peer group reporting scheme, and EQA from the Randox International Quality Assurance Scheme (RIQAS).  Evidence provides multi-analyte test results of the highest quality available.  Biochip arrays already available include cardiac, cerebral, cytokines, adhesion molecules, Drugs of Abuse, anti-microbials, growth promoters, and the RanplexCRC Array for colorectal cancer screening.  Many laboratories around the world are already using the biochip platform and benefiting from better diagnosis.    About Randox Randox is an international diagnostics company, headquartered in the UK.  Randox develop, manufacture and market clinical diagnostic products worldwide.  Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; recombinant proteins and antibodies.   For further information contact:   Randox Laboratories Diamond Road Crumlin Co. Antrim BT29 4QY United Kingdom   Tel: +44 (0) 28 9442 2413 Fax: +44 (0) 28 9445 2912 marketing@randox.com www.randox.com